Dana-Farber Researchers to Present Two Plenary Studies and Additional Late-Breaking Cancer Research at 2026 ASCO
Dana-Farber Cancer Institute researchers will present findings at the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) from several studies with compelling and potentially practice-changing results spanning multiple cancer types, including pancreatic, prostate, breast, and multiple myeloma.
